CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company
Taysha Gene Therapies, Inc.
Sign in to watch- Ticker
- TSHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843199512
- Phone
- (214) 612-0000
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
- 8-K/A Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K/A Event Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- D Other Notice of Sales of Unregistered Securities
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 8-K/A Event Material agreement · Unregistered share sale · Other events
- 8-K Event Material agreement · Other events
Page 13 of 21 · 403 filings